Claudia Maria Rodrigues Alves, Manuel Pereira Marques Gomes Jr., Ricardo Peressoni Faraco, Tatiana Sawabini, Paulo Cézar Ferraz Dias Filho, Hilton Muniz Leão Filho
Gustavo do Prado Monteiro, J. Ribamar Costa Jr., Carlos Collet, Juliano Slhessarenko, Fausto Feres, Ricardo Costa, Áurea J. Chaves, Marinella Centemero, Amanda G.M.R. Sousa,...
Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...
Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...
